KaNDy
Bayer Takes on Astellas in Purchase of Experimental ...
Bayer moved to acquire a prospective non-hormonal menopause relief for an initial $425 million to strengthen its women’s healthcare business, in a challenge to a similar development venture at Astellas.
...
August 13, 2020
9:40 am By Neha Mule